心力衰竭与减少的喷射分数和心室二次 mitrale 吐:一个整体的方法
Marianna Adamo1, Matteo Pagnesi1, Nina Ajmone Marsan2
1Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Cardiology and Cardiac Catheterization Laboratory, ASST Spedali Civili, University of Brescia, Piazza Mercato, 1, 25123 Brescia, Italy.
European heart journal
|August 1, 2025
概括
降低射出分数 (HFrEF) 和二次 mitrale regurgitation (SMR) 的心力衰竭的最佳管理包括指南导向医学疗法 (GDMT),心脏再同步疗法 (CRT) 和 mitrale transcatheter 边缘到边缘修复 (M-TEER). M-TEER可以提高GDMT的耐受性.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
- 干预心脏病学 干预心脏病学
背景情况:
- 降低射出分数 (HFrEF) 的心力衰竭通常与二次美特拉反 (SMR) 共同存在.
- 最佳的管理需要整合指南导向医学治疗 (GDMT),心脏再同步治疗 (CRT) 和 mitra transcatheter 边缘到边缘修复 (M-TEER).
- GDMT和CRT可以降低SMR的严重程度,但由于低血压和功能障碍,GDMT可能耐受不良.
研究的目的:
- 审查当前关于管理HFrEF与心室SMR的知识.
- 专注于GDMT和CRT对SMR严重性的影响.
- 评估成功的M-TEER对GDMT耐受性的影响.
主要方法:
- 最先进的综述,总结现有文献.
- 分析整个患者途径:诊断,治疗和随访.
- 专注于GDMT,CRT和M-TEER在SMR的HFrEF患者之间的相互作用.
主要成果:
- 无论是GDMT还是CRT都能减轻SMR的严重程度.
- M-TEER可以增强前进中风体积,血压和 perfusion,可能改善GDMT的耐受性.
- M-TEER可以作为GDMT的启用疗法,类似于CRT.
结论:
- 在患有不耐受症的HFrEF和SMR患者中,M-TEER可以促进GDMT.
- 即使在干预后,患有HFrEF和SMR的患者仍然存在高风险,需要仔细跟踪和继续GDMT.
- 考虑到GDMT,CRT和M-TEER的综合管理对于优化SMR的HFrEF结果至关重要.
更多相关视频
相关概念视频
01:28Mitral Regurgitation IV: Nursing Management
80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80
01:20Mitral Regurgitation I: Introduction
53
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53
01:25Mitral Regurgitation III: Medical Management
27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
47
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
47
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39